Gu, S.; Hu, X.; Shi, L.; Zhen, X.; Sun, X.; Huang, M.; Gu, Y.; Dong, H.
Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022, 11, 7094.
https://doi.org/10.3390/jcm11237094
AMA Style
Gu S, Hu X, Shi L, Zhen X, Sun X, Huang M, Gu Y, Dong H.
Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2022; 11(23):7094.
https://doi.org/10.3390/jcm11237094
Chicago/Turabian Style
Gu, Shuyan, Xiaoqian Hu, Lizheng Shi, Xuemei Zhen, Xueshan Sun, Minzhuo Huang, Yuxuan Gu, and Hengjin Dong.
2022. "Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis" Journal of Clinical Medicine 11, no. 23: 7094.
https://doi.org/10.3390/jcm11237094
APA Style
Gu, S., Hu, X., Shi, L., Zhen, X., Sun, X., Huang, M., Gu, Y., & Dong, H.
(2022). Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 11(23), 7094.
https://doi.org/10.3390/jcm11237094